194 related articles for article (PubMed ID: 37420017)
1. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
2. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
5. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
Front Immunol; 2022; 13():847624. PubMed ID: 35242144
[TBL] [Abstract][Full Text] [Related]
6. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
[TBL] [Abstract][Full Text] [Related]
7. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
Front Endocrinol (Lausanne); 2022; 13():1056310. PubMed ID: 36568076
[TBL] [Abstract][Full Text] [Related]
8. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
Xia F; Yu Z; Deng A; Gao G
Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
[TBL] [Abstract][Full Text] [Related]
9. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
10. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
11. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
[TBL] [Abstract][Full Text] [Related]
12. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma.
Lian H; Han YP; Zhang YC; Zhao Y; Yan S; Li QF; Wang BC; Wang JJ; Meng W; Yang J; Wang QH; Mao WW; Ma J
Mol Oncol; 2019 Oct; 13(10):2227-2245. PubMed ID: 31385424
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy.
Li X; Kang J; Yue J; Xu D; Liao C; Zhang H; Zhao J; Liu Q; Jiao J; Wang L; Li G
Aging (Albany NY); 2023 May; 15(9):3442-3464. PubMed ID: 37142279
[TBL] [Abstract][Full Text] [Related]
17. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
19. The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma.
Wang X; Wan Q; Jin L; Liu C; Liu C; Cheng Y; Wang Z
Front Mol Biosci; 2020; 7():598725. PubMed ID: 33665205
[No Abstract] [Full Text] [Related]
20. Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma.
Orozco CA; Mejía-García A; Ramírez M; González J; Castro-Vega L; Kreider RB; Serrano S; Combita AL; Bonilla DA
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]